Budded virions of the baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) can enter a variety of non-host cells. The capacity of GP64, AcMNPV's endogenous envelope fusion protein, and SeF, the fusion protein from a gp64
Baculoviruses are insect viruses with applications in pest control and production of recombinant proteins for research, diagnostic and therapeutic uses. The type baculovirus, Autographa californica multiple nucleopolyhedrovirus (AcMNPV), can enter a broad range of nonhost cell lines and primary cells (e.g. Volkman & Goldsmith, 1983; Hofmann et al., 1995; Boyce & Bucher, 1996; Condreay et al., 1999; Airenne et al., 2000; Tani et al., 2001; Ho et al., 2005; Ping et al., 2006; Song et al., 2006) . Therefore, AcMNPV is used as a vector for delivering genes into mammalian cells for applications such as cell-based drug screening (reviewed by Kost et al., 2005) . The potential use of AcMNPV in additional applications such as immunization against infectious disease (Lu et al., 2007) , tissue regeneration (Chuang et al., 2007) , cancer therapy Mäkelä et al., 2006 Mäkelä et al., , 2008 and gene therapy is also being explored (reviewed by Hu, 2006; van Oers, 2006) . Two types of envelope fusion protein (GP64 and F) have been identified in members of the family Baculoviridae (reviewed by Pearson & Rohrmann, 2002) .
The two proteins appear to utilize different receptors for entry into insect Sf21 cells (Westenberg et al., 2007) ; however, receptors for neither protein have been identified. Following binding, AcMNPV entry into insect Sf21 and mammalian BHK-21 and HepG2 cells occurs primarily by clathrin-mediated endocytosis (Matilainen et al., 2005; Long et al., 2006) . As virus binding to and entry into nontarget cells could reduce efficacy and could have negative consequences on unintended target cells, the promiscuity of AcMNPV may be undesirable for in vivo applications that require gene delivery into specific cell types. Kitagawa et al. (2005) demonstrated that specific targeting of AcMNPV to cells expressing measles virus envelope glycoproteins can be achieved by substituting AcMNPV's envelope fusion protein GP64 with CD46 or SLAM, receptors of measles virus. These viruses, however, cannot be propagated easily because GP64 is an essential protein involved in virus attachment, envelope fusion and budding (Blissard & Wenz, 1992; Hefferon et al., 1999; Lung et al., 2002) . A gp64-null AcMNPV vector for targeted transduction could potentially be generated by combining virus envelope modification with targeting molecules and substitution of GP64 with functional homologues that have minimal tropism for vertebrate cells. Genes encoding the G protein from vesicular stomatitis virus (VSV-G) and F proteins from baculoviruses without a gp64 gene, such as Spodoptera exigua multiple nucleopolyhedrovirus (SeMNPV), Lymantria dispar multiple nucleopolyhedrovirus, Helicoverpa armigera nucleopolyhedrovirus (HearNPV) and Agrotis segetum granulovirus, have all been shown to rescue a gp64-null mutant (Mangor et al., 2001; Lung et al., 2002; Liang et al., 2005; Yin et al., 2008) . However, VSV-G-pseudotyped gp64-null AcMNPV is unlikely to be suitable for targeted transduction, as it appears to have even broader species and tissue tropism than viruses with the endogenous GP64 protein (Barsoum et al., 1997) . In contrast, existing evidence suggests that F proteins from baculoviruses without a gp64 gene might not mediate transduction of mammalian cells. Liang et al. (2005) reported no transduction of five different mammalian cell lines (BHK, HepG2, HeLa, Vero and PK15) by HearNPV at an m.o.i. of 50, and Westenberg et al. (2007) reported no transduction of three mammalian cell lines (LLC-PK-1, BHK-21 and H35) by a gp64-null AcMNPV pseudotyped with the F protein from SeMNPV (SeF) at an m.o.i. of 100. This study further examines the tropism of SeFpseudotyped gp64-null AcMNPV for vertebrate cells by comparing transduction of recombinant AcMNPV with either the endogenous GP64 envelope protein or the SeF protein into 17 different cell lines from a wide range of vertebrates, including primate (n54), bovine (n51), porcine (n52), ovine (n51), canine (n51), feline (n51), murine (n52), avian (n51) and piscine (n54) species.
Three AcMNPV bacmid variants carrying the humanized Renilla green fluorescent protein (hrGFP) gene under the control of a cytomegalovirus (CMV) promoter were generated for the study (Fig. 1a) . The variants either had the endogenous envelope protein gene, gp64, or had the open reading frame of SeF under the control of a gp64 promoter instead of a gp64 gene. All PCR-derived regions of the constructs were confirmed by sequencing and all bacmid constructs were confirmed by PCR using the following strategy (data not shown). The M13 forward primer in combination with a primer specific for gp64, SeF or the b-glucuronidase (GUS) gene was used to confirm the transposition of the envelope protein genes and/or the GUS gene. The M13 reverse primer was used in combination with an hrGFP-specific primer to confirm the transposition of the hrGFP gene. M13 forward and reverse primers were used to rule out the presence of bacmids without a Tn7 insert. All three recombinant viruses generated by using the bacmids were also confirmed by PCR analysis using primer pairs specific for the GUS, SeF and gp64 genes (Fig. 1b) . Western blot confirmation of viral envelope protein expression was also performed by using mouse anti-GP64 antibody (AcV5; a gift of Dr Gary Blissard, Boyce Thompson Institute for Plant Research, Ithaca, NY, USA) and chicken anti-SeF1 and anti-SeF2 antibody (Westenberg et al., 2002) (Fig. 1c) . As SeF-pseudotyped gp64-null virus is expected to transduce the cells poorly, a high m.o.i. of 500 was used to enhance detection of transduction by the SeF-pseudotyped virus. Transductions in duplicate wells of vertebrate cell lines were also performed in PBS for 6 h at room temperature, as a similar protocol was previously reported to give higher transduction efficiencies than other protocols (Hsu et al., 2004) . Transduced cells were cultivated at room temperature (piscine cell lines), 37 u C (mammalian cell lines) or 39 u C (avian cell line) for 24 h after transduction, fixed with 10 % formalin and stained with DAPI (49,6-diamidino-2-phenylindole). Images of DAPI and GFP fluorescence were captured for two or more random fields per well and the numbers of GFP-positive cells and DAPI-stained cells (total cells) in the micrographs were determined manually or in combination with Image-Pro 6.2 software (Media Cybernetics). The transduction efficiency was determined by determining the mean of the percentages of DAPI-stained cells that were also GFP-positive from duplicate wells.
Using an m.o.i. of 500, all 17 cell lines tested were transduced with varying efficiencies by viruses with the endogenous envelope protein (AcBac and/or gp64 2 AcBac/ gp64 repair). Transduction efficiencies of the GP64-expressing viruses were determined for 14 of the 17 cell lines tested (Table 1) . Both GP64-containing viruses efficiently transduced human hepatocellular liver carcinoma HepG2 cells (approx. 96 %) and many kidney-derived cell lines (Table 1 AcBac/ gp64 repair virus into two human colonic adenocarcinoma cell lines were approximately 9.9 % for Caco-2 cells and 16.6 % for T84 cells. Transduction efficiencies of GP64-expressing viruses were not determined for three of the cell lines (MDBK, SCP and BHK-21), due to the morphology of these cells and the clumping characteristics of BHK-21 cells (Fig. 2 and data not shown) .
In contrast to the GP64-expressing recombinant AcMNPV variants, which transduced all 17 cell lines to some degree at an m.o.i. of 500, SeF-pseudotyped gp64-null virus (gp64 2 AcBac/SeF) showed no detectable transduction of seven of the 17 cell lines (human colonic adenocarcinomas Caco-2 and T84, ovine SCP, chicken UMNSAH/DF-1, canine MDCK, porcine PK-15 and piscine RTG-2 cells). Transduction efficiency was very low in BHK-21 cells and was ,0.35 % for six other mammalian cell lines (bovine MDBK, 0.34 %; porcine ST, 0.14 %; murine McCOY, 0.13 %; feline FKC, 0.17 %; simian Vero, 0.18 %; human HepG2, 0.15 %). All post-transduction inocula used for dropped by approximately 4.5-fold (from 41.3 to 9.3 %) and 2.5-fold (from 59.1 to 24 %), respectively. These results indicate that the transduction of these mammalian cell lines by the SeF-pseudotyped gp64-null virus can be reduced by lowering the virus : cell ratio. Of the 17 cell lines tested, transduction efficiency of the SeF-pseudotyped gp64-null virus was highest in three fish cell lines (EPC, SSN-1 and CHSE-214), with efficiencies ranging from 1.3 to 5.2 %. Of the four piscine cell lines tested, transduction of EPC cells by the SeF-pseudotyped gp64-null virus had the most significant drop (33-fold) from that of the nearisogenic control virus (1.3 versus 43.3 %). In all cases where transduction efficiencies were determined, statistical analysis using a Mann-Whitney U test showed that the transduction efficiencies of the SeF-pseudotyped gp64-null virus were significantly lower than that of the near-isogenic control (gp64 2 AcBac/gp64 repair) virus. These results indicate that the SeF-pseudotyped gp64-null (gp64 2 AcBac/SeF) virus has significantly narrower tropism for vertebrate cells than AcMNPV with the endogenous envelope protein GP64. A desirable vector for targeted gene delivery would have minimal binding to and entry into non-target cells. However, whether the reduced transduction of vertebrate cells observed with the SeF-pseudotyped gp64-null virus is due to reduced binding and entry or to inefficient processes downstream of binding, such as clathrin-mediated endocytosis, fusion of virus and endosomal membranes or nuclear translocation of nucleocapsids, remains to be determined. This study reports, for the first time, transduction efficiencies of SeF-pseudotyped gp64-null AcMNPV (gp64 2 AcBac/SeF) in 16 vertebrate cell lines, and transduction efficiencies of AcMNPV with the endogenous GP64 protein in human Caco-2 and T84, feline FKC, porcine ST, chicken UMNSAH/DF-1 and fish SSN-1 cells. The results showing that GP64-containing AcMNPV can efficiently transduce HepG2 and BHK-21 cells, but not MDCK cells, are consistent with previous reports (Hofmann et al., 1995; Liang et al., 2004) . Transduction efficiencies of three fish cell lines by AcMNPV with the endogenous envelope fusion protein GP64 and of BHK-21 cells by the SeFpseudotyped gp64-null virus presented in this study were higher than those reported for these cell lines previously. By using a GP64-containing virus with a different reporter, Leisy et al. (2003) reported no transduction of RTG-2 cells, ,0.5 % transduction for EPC cells in the absence of sodium butyrate and only approximately 0.05 % transduction for CHSE-214 cells in the presence of sodium butyrate. Recently, Westenberg et al. (2007) reported that SeFpseudotyped gp64-null AcMNPV carrying a CMV-eGFP reporter cassette showed no detectable transduction of BHK-21, LLC-PK1 or H35 cells, whilst in this study, a very low level of transduction was detected in BHK-21 cells, as well as ST, McCOY, FKC, Vero and HepG2 cells. These discrepancies from previous reports could be due to differences in the reporter gene cassettes used or due to the higher m.o.i. (500 versus 100 or 200), the longer duration of transduction (6 vs 1 h) and other differences in the transduction protocol used between the studies (e.g. 25 uC in Dulbecco's PBS versus 25 uC in cell-culture medium). Recently, two new methods that could potentially generate genetically engineered AcMNPV for targeted transduction have been reported by Zhou & Blissard (2008) . One method would require fusion of heterologous proteins for targeting with the C terminus of the VSV-G protein, which consists of part of the ectodomain and the entire transmembrane and cytoplasmic domains. The second method would require fusion of a heterologous protein for targeting in between 38 aa from the N terminus of the mature GP64 protein and 52 aa from the C terminus of GP64. Both of these methodologies could potentially be used to generate AcMNPV for targeted transduction; however, whether the remnant GP64 or VSV-G sequences 
